Pinkerton Wealth LLC Has $3.70 Million Stock Holdings in Elevance Health, Inc. $ELV

Pinkerton Wealth LLC boosted its stake in Elevance Health, Inc. (NYSE:ELV) by 53.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 11,444 shares of the company’s stock after acquiring an additional 4,005 shares during the quarter. Pinkerton Wealth LLC’s holdings in Elevance Health were worth $3,698,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vestmark Advisory Solutions Inc. acquired a new stake in shares of Elevance Health during the 2nd quarter valued at $730,000. Prospera Financial Services Inc increased its holdings in Elevance Health by 335.0% in the 2nd quarter. Prospera Financial Services Inc now owns 5,412 shares of the company’s stock worth $2,107,000 after purchasing an additional 4,168 shares in the last quarter. Los Angeles Capital Management LLC raised its position in Elevance Health by 354.7% in the second quarter. Los Angeles Capital Management LLC now owns 5,156 shares of the company’s stock valued at $2,005,000 after purchasing an additional 4,022 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Elevance Health by 57.0% in the second quarter. Parkside Financial Bank & Trust now owns 702 shares of the company’s stock valued at $273,000 after purchasing an additional 255 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of Elevance Health by 5,204.0% during the second quarter. Acadian Asset Management LLC now owns 186,754 shares of the company’s stock valued at $72,628,000 after purchasing an additional 183,233 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ELV. TD Cowen restated a “buy” rating on shares of Elevance Health in a report on Wednesday, November 26th. Barclays dropped their price objective on shares of Elevance Health from $404.00 to $393.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Jefferies Financial Group reduced their target price on shares of Elevance Health from $401.00 to $395.00 and set a “buy” rating on the stock in a report on Friday, January 30th. Royal Bank Of Canada cut shares of Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 price target for the company. in a research report on Tuesday, February 3rd. Finally, Truist Financial dropped their price target on shares of Elevance Health from $400.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, February 2nd. Twelve analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Elevance Health presently has an average rating of “Moderate Buy” and a consensus price target of $390.55.

Elevance Health Stock Down 3.1%

Shares of NYSE ELV opened at $280.80 on Tuesday. The company has a market capitalization of $61.98 billion, a P/E ratio of 11.18, a price-to-earnings-growth ratio of 1.60 and a beta of 0.51. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $458.75. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 1.54. The company’s 50 day moving average price is $343.29 and its 200-day moving average price is $335.14.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The company had revenue of $49.31 billion during the quarter, compared to analysts’ expectations of $49.52 billion. During the same period in the prior year, the company posted $3.84 earnings per share. Elevance Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Equities analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th will be issued a dividend of $1.72 per share. This represents a $6.88 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Tuesday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. Elevance Health’s dividend payout ratio (DPR) is 27.23%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.